White Paper

Monitoring Compounds in Workers’ Compensation

Three in four injured workers received opioids for pain relief in a study of 21 states conducted by the Workers’ Compensation Research Institute (WCRI).

CorVel_3clr_primary_logo_263White Paper Summary

“As prescriptions for compounded drugs become more frequent, safety and necessity must be considered in order to effectively regulate their usage for workers’ compensation programs,” according to Rhonda Moran, Vice President, CorVel Corporation. Prospective management ensures all stakeholders are aware that a compound has been prescribed, and that proper documentation has been received indicating the compound is medically necessary considering patient safety, while also minding payors’ out-of-pocket costs. Remembering the end goal of providing safe, effective treatment to injured workers, compounds must be regulated out of interest of the patient and their employer.


To learn more about CorVel, please visit their website.

CorVel is a national provider of risk management solutions for employers, third party administrators, insurance companies and government agencies seeking to control costs and promote positive outcomes.

Risk Matrix: Presented by Liberty Mutual Insurance

10 Critical Risks Shaping the Health Care Landscape Today

Opioid litigation and workplace violence are top risks for healthcare, but emergency preparedness and cyber security present evolving threats.
By: | December 3, 2018 • 2 min read


















The R&I Editorial Team can be reached at [email protected]